Business Description
Founded in 1998 and headquartered in Austin, Texas, Filana Therapeutics Inc. is a medical research company working to fight brain-wasting diseases. Its most advanced treatment, simufilam, is currently in a Phase 3 trial for Alzheimer's disease, while a separate early-stage tool called SavaDx aims to identify the condition using just a small blood sample. The company was previously called Cassava Sciences Inc. before adopting its current name in March 2026.
